BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 456715)

  • 1. [Plasmapheresis in the management of systemic lupus erythematosus].
    Wätzig V; Thiel W; Schreiber G
    Dermatol Monatsschr; 1979 Apr; 165(4):305-7. PubMed ID: 456715
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmapheresis combined with corticosteroids and cyclophosphamide in uncontrolled active systemic lupus erythematosus.
    Schildermans F; Dequeker J; Van de Putte I
    J Rheumatol; 1979; 6(6):687-90. PubMed ID: 529252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The therapeutic potential of plasmapheresis in systemic lupus erythematosus (SLE).
    Swaak AJ
    Neth J Med; 1988 Oct; 33(3-4):155-9. PubMed ID: 3226448
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of plasmapheresis in the treatment of systemic lupus erythematosus].
    Leibowitz G; Ben-Yehuda A; Naparstek Y
    Harefuah; 1990 Mar; 118(6):329-33. PubMed ID: 2189809
    [No Abstract]   [Full Text] [Related]  

  • 5. Plasmapheresis for systemic lupus erythematosus.
    Wallace DJ
    J Rheumatol; 1991 Feb; 18(2):304-5. PubMed ID: 2023229
    [No Abstract]   [Full Text] [Related]  

  • 6. [Initial experience in the treatment of systemic lupus erythematosus using plasmapheresis].
    Simcíková B; Opat P; Rysánek K; Bucek J; Lokaj J; Podrouzková D; Mayer P
    Cas Lek Cesk; 1985 Aug; 124(35):1097-101. PubMed ID: 4028096
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of plasmapheresis in a patient with systemic lupus erythematosus and necrotizing cutaneous ulcers.
    Fruchter L; Gauthier B; Marino F
    J Rheumatol; 1983 Apr; 10(2):341-3. PubMed ID: 6864694
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasmapheresis in the treatment of systemic lupus erythematosus.
    Błaszczyk M; Chorzelski T; Daszyński J; Gaczkowski A; Jabłońska S; Beutner EH
    Arch Immunol Ther Exp (Warsz); 1981; 29(6):769-72. PubMed ID: 6983871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapy with corticoid pulses, plasmapheresis, and corticoid pulses combined with plasmapheresis in systemic lupus erythematosus].
    Carreira PE; Gómez-Reino JJ; Morillas L; Mateo I; Ibero I; Millet VG; Páramo MJ
    Med Clin (Barc); 1986 Jun; 87(5):179-82. PubMed ID: 3736247
    [No Abstract]   [Full Text] [Related]  

  • 10. The application of plasmapheresis in systemic lupus erythematosus.
    Jones JV
    Prog Clin Biol Res; 1982; 106():81-9. PubMed ID: 6817336
    [No Abstract]   [Full Text] [Related]  

  • 11. [Malignant polyvisceritis caused by systemic lupus erythematosus treated with plasmapheresis].
    Cottafava F; Franchini E; Castellani M; Ginocchio L; Nardelli E; Bertolotto M; Brida di Priò S
    Minerva Pediatr; 1982 Nov; 34(22):987-91. PubMed ID: 7155104
    [No Abstract]   [Full Text] [Related]  

  • 12. [Systemic lupus erythematosus].
    Schröder JO; Euler HH
    Internist (Berl); 1993 Apr; 34(4):351-61. PubMed ID: 8486478
    [No Abstract]   [Full Text] [Related]  

  • 13. Short and longterm experience with plasmapheresis in connective tissue diseases.
    Dequeker J; Geusens P; Wielands L
    Biomedicine; 1980 Dec; 32(4):189-94. PubMed ID: 7470581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of systemic lupus erythematosus (I)].
    Font J; Cardellach F; Ingelmo M
    Med Clin (Barc); 1986 Apr; 86(14):604-9. PubMed ID: 3724270
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic plasmapheresis in the combined therapy of systemic lupus erythematosus (a case report)].
    Kalinin NN; Pashinin AN; Alekberova ZS; Folomeev MIu; Kliukvina NG
    Ter Arkh; 1993; 65(7):85-6. PubMed ID: 8211790
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of plasmapheresis on T anc B lymphocyte functions in patients with systemic lupus erythematosus: a double blind study.
    Tsokos GC; Balow JE; Huston DP; Wei N; Decker JL
    Clin Exp Immunol; 1982 May; 48(2):449-57. PubMed ID: 6213330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic lupus erythematosus XII: Cytotoxic therapy and pheresis.
    Stevens MB
    Md State Med J; 1984 Jul; 33(7):538-40. PubMed ID: 6381919
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasmapheresis and subsequent pulse cyclophosphamide in severe systemic lupus erythematosus. An interim report of the Lupus Plasmapheresis Study Group.
    Euler HH; Guillevin L
    Ann Med Interne (Paris); 1994; 145(5):296-302. PubMed ID: 7985935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmapheresis in systemic lupus erythematosus: effects on cellular immunity.
    Vangelista A; Frascà GM; Nanni-Costa A; Bonomini V
    Trans Am Soc Artif Intern Organs; 1983; 29():749-53. PubMed ID: 6608818
    [No Abstract]   [Full Text] [Related]  

  • 20. [Plasmapheresis therapy in severe lupus erythematosus D.N.A. serum antodies and erythrocyte sedimentation rate for therapy control (author's transl)].
    Meffert H; Böhm F; Apostoloff E; Kramm HJ
    Dermatol Monatsschr; 1980 May; 166(5):331-5. PubMed ID: 6968281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.